http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2367587-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04a9c30b01a6909696dc92e883f241c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-14 |
| filingDate | 2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce11564d4afc3df76fefffa6a1d486de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d88900f6fe6b52efcaa8d6cd9fbd1a75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d0adb9e4ba3d85ccb86fcff8a27667 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43eee955e6805f8250a9bf103d8dc69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfd463d89b18984a2db1a8b9c332be2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9c119565209dc7d9e6c5090bae9f12 |
| publicationDate | 2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2367587-T3 |
| titleOfInvention | TIADIAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER. |
| abstract | A compound of formula ** Formula ** in which R1A is -H, R2A is -CO (CH2) 4CH3 and R4A is -CH2NHSO2CH3; or a compound of formula ** Formula ** in which R1A is -H, R4A is -CH2NHSO2CH3 and R5A is -phenyl; R1A is -H, R4A is -CH2NHSO2CH2CH3 and R5A is -phenyl; R1A is -H, R4A is - (CH2) 2NHSO2CH3 and R5A is -phenyl; or a compound of formula ** Formula ** in which R1A is -H, R4A is - (CH2) 2NHSO2CH3 and R5A is -phenyl; or R1A is -H, R4A is -CH2NHSO2CH3 and R5A is -phenyl; or a compound of formula ** Formula ** in which R2A is -COC (CH3) 3, R3A is -CONCH3 and R4A is -CH2NHSO2CH3; R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is -CH2NHSO2CH2Cl; R2A is -COCH3, R3A is -COCH3 and R4A is -CH2NHSO2CH2Cl; R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is -CH2NHSO2CH = CH2; R2A is -COC (CH3) 3, R3A is -COC (CH3) 3 and R4A is -CH2NHSO2CH = CH2; R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is ** Formula ** R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is -CH2NHSO2 (CH2) 2NHCH2CH3; R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is -CH2NHSO2 (CH2) 2N (CH3) 2; R2A is -COC (CH3) 3, R3A is -COCH3 and R4A is -CH2NHSO2 (CH2) 2NH (CH2) 2OH R2A is -COC (CH3) 3, R3A is -COC (CH3) 3 and R4A is -CH2NHSO2 (CH2 ) 2NHCH2CH3; R2A is -COC (CH3) 3, R3A is -COC (CH3) 3 and R4A is -CH2NHSO2 (CH2) 2N (CH3) 2; R2A is -COC (CH3) 3, R3A is -COCH (CH3) 2 and R4A is - (CH2) 2NHSO2CH3; R2A is -COCH2CH3, R3A is -COCH2CH3 and R4A is - (CH2) 2NHSO2CH3; or R2A is -COC (CH3) 3, R3A is -COCH2CH3 and R4A is - (CH2) 2NHSO2CH3 or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2001-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.